Molecular probes and methods of use
US-10925980-B2 · Feb 23, 2021 · US
US11738099B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11738099-B2 |
| Application number | US-202117182997-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 23, 2021 |
| Priority date | Aug 4, 2014 |
| Publication date | Aug 29, 2023 |
| Grant date | Aug 29, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A molecular probe comprising a linear peptide that includes an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9; a contrast agent; and a non-peptide linker that covalently links the peptide to the contrast agent.
Opening claim text (preview).
Having described the invention, the following is claimed: 1. A molecular probe comprising: a linear peptide that includes an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9; a contrast agent selected from at least one of a metal chelating agent or metallofullerene; and a non-peptide linker that covalently links the peptide to the contrast agent, the linker including a carboxamide or a maleimide. 2. The probe of claim 1 , wherein the non-peptide linker is a non-peptide aliphatic or heteroaliphatic linker. 3. The probe of claim 1 , wherein the non-peptide linker includes an alkylene dicarboxamide. 4. The probe of claim 1 , wherein the contrast agent is a magnetic resonance imaging (MRI), positron emission tomography (PET), or single photon emission computed tomography (SPECT) contrast agent. 5. The probe of claim 3 , wherein the contrast agent is a metal chelating agent selected from diethylenetriaminepentaacetate (DTPA), 1,4,7,10-tetraazadodecanetetraacetate (DOTA), 1,4,7,10-tetraazadodecane-1,4,7-triacetate (DO3A), ethylenediaminetetraacetate (EDTA), 1,4,7,10-tetraazacyclotridecanetetraacetic acid (TRITA), 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA), 1,4,7,10-tetraazadodecanetetramethylacetate (DOTMA), 1,4,7,10-tetraazadodecane-1,4,7-tri methylacetate (DO3MA), N,N′,N″,N′″-tetraphosphonatomethyl-1,4,7,10-tetraazacyclododecane (DOTP), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylene methylphosphonic acid) (DOTMP), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylene phenylphosphonic acid) (DOTPP), or N,N′-ethylenedi-L-cysteine. 6. The probe of claim 1 , having the formula: wherein: P 1 is a linear peptide having an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9; L 1 is an optional spacer, L 2 is an amino group of the peptide P 1 or the optional spacer if present, and M is a metal selected from the group consisting of Gd +3 , Eu +3 , Tm +3 , Dy +3 , Yb +3 , Mn +2 , Fe +3 , 55 Co, 64 Cu, 67 Cu, 47 Sc, 66 Ga, 68 Ga, 90 Y, 97 Ru, 99 mTc, 111 In, 109 Pd, 153 Sm, 177 Lu, 186 Re, and 188 Re; or salts thereof. 7. The probe of claim 6 , wherein L 1 is selected from at least one of a polyalkyleneoxide, polyvinyl alcohol, polyethylene glycol (PEG), polypropylene glycol (PPG), co-polyethylene-polypropylene glycol, polyoxyethylene (POE), polyurethane, polyphosphazene, polysaccharides, dextran, polyvinylpyrrolidones, polyvinyl ethyl ether, polyacryl amide, polyacrylate, or polycyanoacrylates. 8. The probe of claim 1 , having the formula: wherein: P 1 is a linear peptide having an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9; L 2 is an amino group of the peptide P 1 , and M is a metal selected from the group consisting of Gd +3 , Eu +3 , Tm +3 , Dy +3 , Yb +3 , Mn +2 , Fe + , 55 Co, 64 Cu, 67 Cu, 47 Sc, 66 Ga, 68 Ga, 90 Y, 97 Ru, 99 mTc, 111 In, 109 Pd, 153 Sm, 177 Lu, 186 Re, and 188 Re, and n is an integer from 0 to 100; or salts thereof. 9. The probe of claim 1 , wherein the metallofullerene is Gd3N@C80.
Peptides, e.g. proteins · CPC title
Methine dyes, e.g. cyanine dyes · CPC title
Peptides, proteins, polyamino acids · CPC title
conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.